Structural Biology
Mechanism of beta-arrestin 1 mediated Src activation via Src SH3 domain revealed by cryo-electron microscopy
This study leverages cryo-electron microscopy to elucidate the molecular mechanisms by which beta-arrestin 1 (βarr1) recruits and activates the non-receptor tyrosine kinase Src, revealing dual binding sites and allosteric activation.
Executive Impact: Key Metrics for Enterprise AI Integration
Advanced structural biology techniques, augmented by AI, offer unprecedented precision in understanding molecular mechanisms, leading to accelerated drug discovery and development.
0 Å
Resolution Achieved
0
Key Interaction Sites Identified
0%
Src Activation Demonstrated
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Unveiling the molecular architecture of key protein complexes.
3.32 Å
Cryo-EM Resolution for Src-βarr1-CC Complex
Enterprise Process Flow
Sample Preparation & Disulfide Trapping
→
Cryo-EM Grid Preparation
→
Data Acquisition
→
Image Processing & 3D Reconstruction
→
Model Building & Refinement
→
Structural Validation
| Feature | βarr1-N Site | βarr1-CC Site |
|---|---|---|
| Recognition Mechanism |
|
|
| Interaction Surface |
|
|
| Dynamic Nature |
|
|
| Activation Requirement |
|
|
Understanding the biological consequences of βarr1-mediated Src activation.
βarr1-Mediated Src Activation
The study reveals that βarr1 acts as an active regulatory protein, not just a passive scaffold, by directly disrupting the autoinhibited conformation of Src. This allosteric activation mechanism is critical for understanding GPCR signaling cascades and could have implications for diseases like cancer where Src is overexpressed.
The direct activation of Src by βarr1 provides a novel therapeutic target for modulating GPCR signaling and Src-related pathologies.
Dual-site
βarr1 Interaction Strategy with Src SH3
Estimate Your Potential AI Efficiency Gains
Utilize our calculator to understand the potential time and cost savings from implementing similar advanced structural biology analysis platforms in your enterprise R&D pipeline.
Estimated Annual Savings
Hours Reclaimed Annually
Your Enterprise AI Integration Roadmap
A strategic phased approach for integrating advanced cryo-EM analysis and AI-driven insights into your drug discovery and structural biology workflows.
Phase 1: Assessment & Customization
Evaluate existing infrastructure, identify key integration points, and tailor AI models to specific research objectives and data formats.
Phase 2: Pilot Deployment & Validation
Implement the solution in a controlled environment, run pilot studies with real data, and validate accuracy and efficiency against established benchmarks.
Phase 3: Scaled Integration & Training
Expand deployment across relevant departments, integrate with enterprise-level data platforms, and provide comprehensive training for R&D teams.
Phase 4: Continuous Optimization & Support
Establish monitoring protocols, conduct regular performance reviews, and ensure ongoing support and updates for sustained impact.
Ready to Transform Your R&D?
Connect with our experts to discuss how these AI-driven structural biology insights can be tailored to your organization's unique challenges and opportunities.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat